requirements of propofol / etomidate for loss of consciousness among old patients.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032347

Enrollment

Unknown

Registered

2020-04-26

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmacodynamics

Interventions

85 years group:propofol/etomidate

Eligibility

Sex/Gender

All

Age

45 Years to 95 Years

Inclusion criteria

Inclusion criteria: ASA 1-3; aged 45-64 years old; 65-85 years old; old than 85 years old.

Exclusion criteria

Exclusion criteria: Patients with known adrenocortical insufficiency, chronic sedative or opioid analgesic use, known allergy to the study drugs, heart failure (ejection fraction <40%), and/or severe respiratory disease (vital capacity and/or forced expiratory volume <50%) preoperatively were excluded from this study.

Design outcomes

Primary

Measure	Time frame
requirements of propofol / etomidate;	—

Secondary

Measure	Time frame
vital signs;	—

Countries

China

Contacts

Public ContactJinchao Song

Department of Anesthesiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

sjch2013@163.com+86 13167000520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026